Abstract:Unorthodox F-18-labeling strategies not employing the formation of a carbon-18F bond are seldom found in radiochemistry. Historically, the formation of a boron- or silicon-F-18 bond has been introduced very early on into the repertoire of labeling chemistries, but is without translation into any clinical radiotracer besides inorganic B[F-18]F-4(-) for brain tumor diagnosis. For many decades these labeling methodologies were forgotten and have just recently been revived by a handful of researchers thinking outside the box. When breaking with established paradigms such as the inability to obtain labeled compounds of high specific activity via isotopic exchange or performing radiofluorination in aqueous media, the research community often reacts skeptically. In 2005 and 2006, two novel labeling methodologies were introduced into radiochemistry for positron emission tomography (PET) tracer development: RBF3 labeling reported by Perrin et al. and the SiFA methodology by Schirrmacher, Jurkschat, and Waengler et al. which is based on isotopic exchange (IE). Both labeling methodologies have been complemented by other noncanonical strategies to introduce 18F into biomolecules of diagnostic importance, thus profoundly enriching the landscape of F-18 radiolabeling. B- and Si-based labeling strategies finally revealed that IE is a viable alternative to established and traditional radiochemistry with the advantage of simplifying both the labeling effort as well as the necessary purification of the radiotracer. Hence 1E, will be the focus of this contribution over other noncanonical labeling methods. Peptides for tumor imaging especially lend themselves favorably toward one-step labeling via IE, but small molecules have been described as well, taking advantage of these new approaches, and have been used successfully for brain imaging. This Review gives an account of both radiochemistries centered on boron and silicon, describing the very beginnings of their basic research, the path that led to optimization of their chemistries, and the first encouraging preclinical results paving the way to their clinical use. This side by side approach will give the reader the opportunity to follow the development of a new basic discovery into a clinically applicable radiotracer including all the hurdles that have had to be overcome.

Recent Advances in 18F-Labeled Amino Acids Synthesis and Application

Methodological Progress of 18 F-labeled Aromatic PET Radiotracers

New Methods and Techniques for F-18-Labeled Radiopharmaceuticals

Microfluidics for synthesis of peptide-based PET tracers.

From Unorthodox to Established: the Current Status of (18)F-Trifluoroborate- and (18)F-Sifa-based Radiopharmaceuticals in PET Nuclear Imaging.

Synthesis of 18F‐labeled Aryl Trifluoromethyl Sulfones, ‐Sulfoxides, and ‐Sulfides for Positron Emission Tomography

Current Researches and Progress on Preparation of 18F Labeled Positron Radiopharmacueticals

C-H Labeling with [18F]Fluoride: An Emerging Methodology in Radiochemistry

Kit-like 18F-labeling of RGD-19F-arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging.

Simplified one-pot 18F-labeling of biomolecules with in situ generated fluorothiophosphate synthons in high molar activity

Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design.

Advances in [18F]Trifluoromethylation Chemistry for PET Imaging

Design of Novel 18 F-Labeled Amino Acid Tracers Using Sulfur 18 F-Fluoride Exchange Click Chemistry

Research progress of 18F labeled small molecule positron emission tomography (PET) imaging agents

Convergent F-18 radiosynthesis: A new dimension for radiolabelling

Difluoromethyl Radical Reaction and Its Application in 18F-Labeling

One-step Radiosynthesis of 18F-Alf-nota-rgd2 for Tumor Angiogenesis PET Imaging

Click Labeled Peptides with Fluorine-18 for PET Imaging

Synthesis and Biological Evaluation of Fluorine-18 and Deuterium Labeled l-Fluoroalanines as Positron Emission Tomography Imaging Agents for Cancer Detection

Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics

Synthesis and application of 4-[(18)F]fluorobenzylamine: A versatile building block for the preparation of PET radiotracers